NR3C1 and Cushing syndrome: Characteristics of current and recent clinical trials, registered in clinicaltrials.gov, on glucocorticoid-receptor antagonists for the treatment of Cushing's disease and Cushing's syndrome in terms of official study name, identification code, study design, patient number, start, and completion date.